Providence Microbiome Research Center Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 4 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 97.95%
(FY 2023)
- Ebitda 97.95%
(FY 2023)
- Net Worth -0.02%
(FY 2023)
- Total Assets -49.53%
(FY 2023)
About Providence Microbiome Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrashekhar Thodupunuri and Keerthi Sarabu serve as directors at the Company.
- CIN/LLPIN
U73100TG2020PTC143763
- Company No.
143763
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Providence Microbiome Research Center?
Board Members(2)
Financial Performance and Corporate Structure Insights of Providence Microbiome Research Center.
Providence Microbiome Research Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.95% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Providence Microbiome Research Center?
In 2023, Providence Microbiome Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Serendipity Centre For Community Health Private Limited
Active
29 years 4 months Chandrashekhar Thodupunuri is a mutual person
Resplice Autism Research Foundation
Active 1 year 10 months Chandrashekhar Thodupunuri is a mutual person
Gutsy Medical Sciences Private Limited
Active 6 months 1 day Chandrashekhar Thodupunuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Providence Microbiome Research Center?
Providence Microbiome Research Center has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 11, 2022, Providence Microbiome Research Center has raised a total of ₹ 90 K, with the most recent deal valued at ₹ 90 K. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
